Nuclear accumulation of β‐catenin protein in Wilms' tumours †

No abstract is available for this paper.

• Publication year

  2003

• Venue

  The Journal of Pathology

• Publication date

  2003-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosome 11 Putative Tumor Suppressor Regions , Is Limited to Loss of Heterozygosity in Wilms ' Tumors , Studied for Six Updated

  2006cited by this paper
• Genetics of Wilms' tumor

  2004cited by this paper
• The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.

  2001cited by this paper
• Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas.

  2000cited by this paper
• Nuclear Localization and Mutation of β‐Catenin in Medulloblastomas

  2000cited by this paper
• AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

  2000cited by this paper
• E-cadherin Is a WT1 Target Gene*

  2000cited by this paper
• Frequent Association of β-Catenin and WT1 Mutations in Wilms Tumors

  2000influential reference
• Activation of β-catenin in epithelial and mesenchymal hepatoblastomas

  2000cited by this paper
• Wnt signaling and cancer.

  2000cited by this paper
• Molecular and biological analysis of carcinoma of the small intestine: β-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype

  2000cited by this paper
• The Wilms’ Tumor Suppressor Gene (wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation

  1999cited by this paper
• Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.

  1999cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.

  1999cited by this paper
• The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.

  1999cited by this paper
• Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.

  1999cited by this paper
• Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.

  1999cited by this paper
• Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.

  1998cited by this paper
• Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations.

  1998cited by this paper
• Mutations in the β-Catenin Gene (CTNNB1) in Endometrioid Ovarian Carcinomas

  1998cited by this paper
• Sporadic Medulloblastomas Contain Oncogenic β-Catenin Mutations

  1998cited by this paper
• β-Catenin Mutations in Human Prostate Cancer

  1998cited by this paper
• Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer

  1998cited by this paper
• Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin

  1998cited by this paper
• Beta-catenin mutation in carcinoma of the uterine endometrium.

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

  1998cited by this paper
• Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients(家族性大腸腺腫症患者の大腸上皮細胞における細胞間接着分子β-カテニンの発現変化)

  1997cited by this paper
• β‐catenin is a target for the ubiquitin–proteasome pathway

  1997cited by this paper
• Beta-catenin mutations in cell lines established from human colorectal cancers.

  1997cited by this paper
• Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors.

  1997cited by this paper
• Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines

  1997cited by this paper
• Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour.

  1997cited by this paper
• A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Comparative genomic hybridization analysis of wilms tumors

  1996cited by this paper
• The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3.

  1996cited by this paper
• Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.

  1996cited by this paper
• Signal transduction of beta-catenin.

  1995cited by this paper
• Mutational analysis of the tumor-suppressor gene wt1 - detection of a novel homozygous point mutation in sporadic unilateral wilms-tumor.

  1995cited by this paper
• WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.

  1995cited by this paper
• Repression of Pax-2 by WT1 during normal kidney development.

  1995cited by this paper
• Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

  1994cited by this paper
• Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.

  1994cited by this paper
• Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

  1994cited by this paper
• Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

  1993cited by this paper
• A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1

  1993cited by this paper
• A third Wilms' tumor locus on chromosome 16q.

  1992cited by this paper
• The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene.

  1992cited by this paper
• APC mutations occur early during colorectal tumorigenesis

  1992cited by this paper
• Thyroid hormone up-regulates NGFI-A gene expression in rat brain during development.

  1992cited by this paper
• Wilms' tumor 1991. Clinical evaluation and treatment.

  1991cited by this paper
• Wilms' tumor 1991. Clinical evaluation and treatment.

  1991cited by this paper
• Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

  1990cited by this paper
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

  1990cited by this paper
• Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours

  1988cited by this paper
• Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study.

  1988cited by this paper
• Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome.

  1985cited by this paper
• Childhood cancer incidence: Geographical and temporal variations

  1983cited by this paper

• LMO family gene polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study

  2024cites this paper
• Stromal beta-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.

  2020cites this paper
• WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.

  2019cites this paper
• LMO2 gene deletions significantly worsen the prognosis of Wilms' tumor development in patients with WAGR syndrome.

  2019cites this paper
• Lessons learned from the developmental origins of childhood renal cancer

  2019cites this paper
• Bilateral Wilms Tumor: A Surgical Perspective

  2018cites this paper
• Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation

  2017cites this paper
• Genetic variation frequencies in Wilms' tumor: A meta‐analysis and systematic review

  2016cites this paper
• Clinical, pathologic, and genetic features of Wilms tumors with WTX gene mutation.

  2016cites this paper
• Edinburgh Research Explorer The Yin and Yang of kidney development and Wilms’ tumours

  2015cites this paper
• The yin and yang of kidney development and Wilms’ tumors

  2015cites this paper
• Epigenetic States of Nephron Progenitors and Epithelial Differentiation

  2015cites this paper
• Molecular-Targeted Therapy for Pediatric Renal Tumors

  2014cites this paper
• Chapter 23 – Wilms Tumors

  2014cites this paper
• N -Methyl- N -nitrosourea-induced Renal Tumors in Rats: Immunohistochemical Comparison to Human Wilms Tumors

  2013cites this paper
• β‐Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid‐type fibromatosis

  2013cites this paper
• Nephroblastoma/Wilms Tumor: A Corrupted Cap Stem Cell Caricature

  2013cites this paper
• Multicentre study of Wilm’s tumours treated by different therapeutic strategies in two different countries

  2013cites this paper
• Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India

  2013cites this paper
• Molecular characterization of Wilms' tumor from a resource‐constrained region of sub‐Saharan Africa

  2012cites this paper
• DEFINIÇÃO DO PERFIL DE ALTERAÇÕES DAS SEQUÊNCIAS DOS GENES APC, CTNNB1, WT1, WTX E PLCG2 EM TUMORES DE WILMS

  2012cites this paper
• Tumor de Wilms con diferenciación muscular. Histología, inmunofenotipo y análisis molecular de tres casos

  2012cites this paper
• SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.

  2012cites this paper
• WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling

  2012cites this paper
• Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset

  2011cites this paper
• Pathology, genetics and cytogenetics of Wilms' tumour

  2011cites this paper
• Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development

  2011cites this paper
• β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.

  2011cites this paper
• Activation of beta-catenin is a late event in the pathogenesis of nephroblastomas and rarely correlated with genetic changes of the APC gene

  2011cites this paper
• Targeting the Wnt pathway in cancer

  2011cites this paper
• Dysregulation of the Wnt Pathway in Solid Tumors

  2011cites this paper
• Molecular Targeted Therapy for Wilms’ Tumor

  2010cites this paper
• Candidate genes and potential targets for therapeutics in Wilms’ tumour

  2010cites this paper
• Nuclear Accumulation of β-Catenin Protein Indicates Activation of wnt Signaling in Chemically Induced Rat Nephroblastomas

  2010influential citation
• Loss of PTEN/MMAC1 activity is a rare and late event in the pathogenesis of nephroblastomas.

  2010cites this paper
• Canonical WNT signalling determines lineage specificity in Wilms tumour

  2009cites this paper
• Wnt/β-Catenin Signaling and Oral Cancer Metastasis

  2009cites this paper
• Inheritance of susceptibility to induction of nephroblastomas in the Noble rat.

  2009cites this paper
• Mutational Analysis of WTX Gene in Wnt/ β-Catenin Pathway in Gastric, Colorectal, and Hepatocellular Carcinomas

  2009cites this paper
• Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome

  2008cites this paper
• Beta‐catenin expression and mutation in adult and pediatric Wilms' tumors  

  2008cites this paper
• IMMUNOHISTOCHEMICAL ANALYSIS OF GAMMA CATENIN IN WILMS' TUMORS

  2008cites this paper
• Functional inactivation of the WTX gene is not a frequent event in Wilms’ tumors

  2008cites this paper
• Mutational Analysis of the Tumor Suppressor WTX Gene in Non-small Cell Lung Cancer

  2008cites this paper
• Analysis of APC/beta‐catenin genes mutations and Wnt signalling pathway in desmoid‐type fibromatosis

  2007cites this paper
• Cyclins are prime cell cycle regulators and play a central role in the control of cell proliferation by forming complexes with different cyclin-dependent kinases

  2007cites this paper
• Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.

  2007cites this paper
• Wnt Signal Transduction

  2007cites this paper
• Wnt signaling as a therapeutic target for cancer.

  2007cites this paper
• Immunohistochemical analysis of cyclin E in Wilms tumors

  2007cites this paper
• Wilms Tumor Suppressor WTX Negatively Regulates WNT/ß-Catenin Signaling

  2007cites this paper
• IMMUNOHISTOCHEMICAL ANALYSIS OF CYCLIN E IN WILMS TUMORS

  2007cites this paper
• Converging on β-Catenin in Wilms Tumor

  2007cites this paper
• CITED1 expression in Wilms' tumor and embryonic kidney.

  2007cites this paper
• beta-Catenin-mediated signaling: a novel molecular target for chemoprevention with anti-inflammatory substances.

  2006cites this paper
• Expression of E‐cadherin, cadherin‐11, &agr;‐, &bgr;‐ and &ggr;‐catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome

  2006cites this paper
• Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

  2006cites this paper
• Identification of a specific inhibitor of the dishevelled PDZ domain.

  2005cites this paper
• Wnt signalling and the mechanistic basis of tumour development

  2005cites this paper
• Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

  2005cites this paper
• Apc deficiency predisposes to renal carcinoma in the mouse

  2005cites this paper
• CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.

  2004cites this paper
• Mutational activation of the RAS‐RAF‐MAPK and the wnt pathway in small intestinal adenocarcinomas

  2004cites this paper
• The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line.

  2004cites this paper
• Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli

  2004cites this paper
• Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of β catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy

  2004cites this paper
• Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers

  2004cites this paper
• Myogenesis in Wilms Tumors Is Associated with Mutations of the WT1 Gene and Activation of Bcl-2 and the Wnt Signaling Pathway

  2004cites this paper
• Differential expression of E-cadherin and β catenin in primary and metastatic Wilms’s tumours

  2003cites this paper